Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 79592 [2015-32017]
Download as PDF
<![CDATA[
79592
Federal Register / Vol. 80, No. 245 / Tuesday, December 22, 2015 / Notices
the four training models, and training
and technical assistance instructors,
coaches and subject matter experts.
CDC will use the information
collected to evaluate the effectiveness of
the Work@Health® Program in terms of
(1) increasing employer’s knowledge
and awareness of worksite health
concepts, principles, and resources, and
(2) increasing the number of sciencebased worksite health programs,
policies and practices in place at
participating employers’ worksites. The
information will also be used to
continue to identify and improve the
best way(s) to deliver skill-based
training and technical support to
employers in the area of worksite
health.
OMB approval is requested for three
years. Participation in Work@Health® is
voluntary and there are no costs to
participants other than their time. The
total estimated annualized burden hours
are 1,047.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Form name
Interested Employer ................
Employers Participating in
Work@Health.
Employer Application Form ....................................................
CDC Worksite Health Scorecard ...........................................
Organizational Assessment ....................................................
Employer Follow-up Survey ...................................................
Case Study Interviews with Senior Leadership .....................
Case Study Interviews with Employees .................................
Trainee KAB Survey ...............................................................
Trainee Reaction Survey—Hands-On Model .........................
Trainee Reaction Survey—Online Model ...............................
Trainee Reaction Survey—Blended Model ............................
Trainee Technical Assistance Survey ....................................
Case Study Interviews with Selected Trainees .....................
Trainee Focus Group Discussion Guide ................................
Train-the-Trainer Application Form ........................................
400
320
320
160
2
4
640
100
120
100
640
10
7
80
1
1
1
1
1
1
1
1
1
1
1
1
1
1
20/60
0.5
15/60
15/60
1
1
20/60
15/60
15/60
15/60
15/60
1
1.5
0.5
Train-the-Trainer Participant Survey ......................................
Trainee Reaction Survey—Train-the-Trainer Model ..............
Train-the-Trainer Trainee Technical Assistance Survey ........
Wave 2 Trainee Reaction Survey ..........................................
80
40
80
200
1
1
1
1
20/60
15/60
15/60
15/60
Instructor/Coach Group Discussion Guide .............................
7
1
0.5
Trainees Participating in the
Work@Health Program
(Hands-on, Online, Blended
models).
Interested Train-the-Trainer
Participants.
Trainees Participating in the
Work@Health Program
(Train-the-Trainer model).
Trainees participating in the
Work@Health Program
Wave 2.
Work@Health Instructors/
Coaches.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–32139 Filed 12–21–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) DP 16–001, Pregnancy Risk
Assessment Monitoring System
(PRAMS).
VerDate Sep<11>2014
17:21 Dec 21, 2015
Jkt 238001
Number of
respondents
Average
burden per
response
(in hrs.)
Type of
respondent
Time and Date: 11:00 a.m.–6:00 p.m.,
EST, Panel C, February 3, 2016 (Closed)
Place: Teleconference
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘FOA DP16–001, Panel C, Pregnancy
Risk Assessment Monitoring System
(PRAMS)’’.
Contact Person for More Information:
Jayalakshmi Raman Ph.D., Scientific
Review Officer, CDC, 4770 Buford
Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488–
6511, kva5@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–32017 Filed 12–21–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 9:30 a.m.–4:00 p.m. EST,
January 28, 2016; 9:30 a.m.–3:00 p.m. EST,
January 29, 2016.
E:\FR\FM\22DEN1.SGM
22DEN1
]]>Agencies
[Federal Register Volume 80, Number 245 (Tuesday, December 22, 2015)]
[Notices]
[Page 79592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32017]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity Announcement (FOA) DP
16-001, Pregnancy Risk Assessment Monitoring System (PRAMS).
Time and Date: 11:00 a.m.-6:00 p.m., EST, Panel C, February 3, 2016
(Closed)
Place: Teleconference
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``FOA DP16-001, Panel C, Pregnancy Risk Assessment Monitoring System
(PRAMS)''.
Contact Person for More Information: Jayalakshmi Raman Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80,
Atlanta, Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-32017 Filed 12-21-15; 8:45 am]
BILLING CODE 4163-18-P
